(19)
(11) EP 1 578 927 A2

(12)

(43) Date of publication:
28.09.2005 Bulletin 2005/39

(21) Application number: 03749047.1

(22) Date of filing: 14.08.2003
(51) International Patent Classification (IPC)7C12N 1/00
(86) International application number:
PCT/US2003/025465
(87) International publication number:
WO 2004/016754 (26.02.2004 Gazette 2004/09)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
Designated Extension States:
AL LT LV MK

(30) Priority: 14.08.2002 US 403416 P

(71) Applicant: Pharmacia Corporation
Chesterfield, MO 63017-1732 (US)

(72) Inventor:
  • ROBERDS, Steven, L.
    Mattawan, MI 49071 (US)

(74) Representative: Courgeon, Antoine 
Pfizer European Pharma Patent Department 23-25, avenue du Docteur Lannelongue
75668 Paris Cedex 14
75668 Paris Cedex 14 (FR)

   


(54) ANTISENSE MODULATION OF NAV1.3 EXPRESSION